Tumor-killing γδ-TCRs take center stage

Abstract

Human γδ T cells potently kill a variety of tumor cells, suggesting their usefulness in cancer therapy. In this issue of Blood, Gründer and colleagues report on in vitro-manipulated γδ-T cell receptors (TCRs) with substantially improved tumor cell recognition and killing characteristics.